{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T06:24:47Z","timestamp":1749536687329,"version":"3.37.3"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s40266-023-01070-0","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T08:23:21Z","timestamp":1699518201000},"page":"1053-1084","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Factors Associated with Psychotropic Medication Use in People Living with Dementia in the Community: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9155-9365","authenticated-orcid":false,"given":"Kerryn L.","family":"Loftus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7811-5225","authenticated-orcid":false,"given":"Anne P. F.","family":"Wand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9932-9513","authenticated-orcid":false,"given":"Juanita L.","family":"Breen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8088-9406","authenticated-orcid":false,"given":"Glenn E.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7934-7001","authenticated-orcid":false,"given":"Carmelle","family":"Peisah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,9]]},"reference":[{"issue":"2","key":"1070_CR1","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/s2468-2667(21)00249-8","volume":"7","author":"GBD 2019 Dementia Forecasting Collaborators","year":"2019","unstructured":"GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2019;7(2):e105\u201325. https:\/\/doi.org\/10.1016\/s2468-2667(21)00249-8.","journal-title":"Lancet Public Health."},{"key":"1070_CR2","unstructured":"Alzheimer\u2019s Association. 2017 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Association. 2017. https:\/\/www.alz.org\/media\/images\/2017-facts-and-figures.pdf. Accessed 05 May 2022."},{"key":"1070_CR3","unstructured":"Royal Commission into Aged Care Quality and Safety. Final report: care, dignity and respect. Commonwealth of Australia. Vol. X. 2021. https:\/\/agedcare.royalcommission.gov.au\/publications\/final-report. Accessed 08 Sep 2022."},{"issue":"4","key":"1070_CR4","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1377\/hlthaff.2013.1247","volume":"33","author":"JPW Bynum","year":"2014","unstructured":"Bynum JPW. The long reach of Alzheimer\u2019s disease: patients, practice, and policy. Health Aff. 2014;33(4):534\u201340. https:\/\/doi.org\/10.1377\/hlthaff.2013.1247.","journal-title":"Health Aff"},{"issue":"4","key":"1070_CR5","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1017\/s0714980818000375","volume":"37","author":"S Johnson","year":"2018","unstructured":"Johnson S, Bacsu J, Abeykoon H, McIntosh T, Jeffrey B, Novik N. No place like home: a systematic review of home care for older adults in Canada. Can J Aging. 2018;37(4):400\u201319. https:\/\/doi.org\/10.1017\/s0714980818000375.","journal-title":"Can J Aging"},{"issue":"10","key":"1070_CR6","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1017\/s1041610216001253","volume":"28","author":"DT Maust","year":"2016","unstructured":"Maust DT. Improving psychotropic medication use among persons with dementia. Int Psychogeriatr. 2016;28(10):1587\u20138. https:\/\/doi.org\/10.1017\/s1041610216001253.","journal-title":"Int Psychogeriatr"},{"issue":"3","key":"1070_CR7","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/gps.5442","volume":"36","author":"KJ Joling","year":"2021","unstructured":"Joling KJ, Koppel MT, van Hout HPJ, Onwuteaka-Philipsen BD, Francke AL, Verheij RA, et al. Psychotropic drug prescription rates in primary care for people with dementia from recorded diagnosis onwards. Int J Geriatr Psychiatry. 2021;36(3):443\u201351. https:\/\/doi.org\/10.1002\/gps.5442.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"7","key":"1070_CR8","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1001\/jama.2020.8519","volume":"324","author":"DT Maust","year":"2020","unstructured":"Maust DT, Strominger J, Bynum JP, Langa KM, Gerlach LB, Zivin K, et al. Prevalence of psychotropic and opioid prescription fills among community-dwelling older adults with dementia in the US. J Am Med Assoc. 2020;324(7):706\u20139. https:\/\/doi.org\/10.1001\/jama.2020.8519.","journal-title":"J Am Med Assoc"},{"issue":"11","key":"1070_CR9","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.euroneuro.2018.04.005","volume":"28","author":"K Orsel","year":"2018","unstructured":"Orsel K, Taipale H, Tolppanen A-M, Koponen M, Tanskanen A, Tiihonen J, et al. Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer\u2019s disease. Eur Neuropsychopharmacol. 2018;28(11):1260\u20139. https:\/\/doi.org\/10.1016\/j.euroneuro.2018.04.005.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"1070_CR10","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1001\/jamapsychiatry.2014.3018","volume":"72","author":"DT Maust","year":"2015","unstructured":"Maust DT, Myra Kim H, Seyfried LS, Chiang C, Kavanagh J, Schneider LS, et al. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. J Am Med Assoc Psychiatry. 2015;72(5):438\u201345. https:\/\/doi.org\/10.1001\/jamapsychiatry.2014.3018.","journal-title":"J Am Med Assoc Psychiatry."},{"issue":"8","key":"1070_CR11","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1017\/s1041610214002816","volume":"27","author":"C Peisah","year":"2015","unstructured":"Peisah C, Strukovski J-A, Wijeratne C, Mulholland R, Luscombe G, Brodaty H. The development and testing of the quality use of medications in dementia (QUM-D): a tool for quality prescribing for behavioral and psychological symptoms of dementia (BPSD). Int Psychogeriatr. 2015;27(8):1313\u201322. https:\/\/doi.org\/10.1017\/s1041610214002816.","journal-title":"Int Psychogeriatr"},{"issue":"9","key":"1070_CR12","doi-asserted-by":"publisher","first-page":"398","DOI":"10.5694\/mja17.00857","volume":"208","author":"JL Westbury","year":"2018","unstructured":"Westbury JL, Gee P, Ling T, Brown DT, Franks KH, Bindoff I, et al. RedUSe: reducing antipsychotic and benzodiazepine prescribing in residential aged care facilities. Med J Aust. 2018;208(9):398\u2013403. https:\/\/doi.org\/10.5694\/mja17.00857.","journal-title":"Med J Aust"},{"issue":"2","key":"1070_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1177\/0004867418758919","volume":"53","author":"J Westbury","year":"2019","unstructured":"Westbury J, Gee P, Ling T, Kitsos A, Peterson G. More action needed: psychotropic prescribing in Australian residential aged care. Aust N Z J Psychiatry. 2019;53(2):136\u201347. https:\/\/doi.org\/10.1177\/0004867418758919.","journal-title":"Aust N Z J Psychiatry"},{"issue":"5","key":"1070_CR14","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jagp.2017.02.010","volume":"25","author":"DT Maust","year":"2017","unstructured":"Maust DT, Kales HC. Bringing precision medicine to the management of BPSD. Am J Geriatr Psychiatry. 2017;25(5):469\u201370. https:\/\/doi.org\/10.1016\/j.jagp.2017.02.010.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"2","key":"1070_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/gps.4452","volume":"32","author":"DT Maust","year":"2017","unstructured":"Maust DT, Langa KM, Blow FC, Kales HC. Psychotropic use and associated neuropsychiatric symptoms among patients with dementia in the USA. Int J Geriatr Psychiatry. 2017;32(2):164\u201374. https:\/\/doi.org\/10.1002\/gps.4452.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"7","key":"1070_CR16","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097.","journal-title":"PLoS Med"},{"issue":"8","key":"1070_CR17","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.eurpsy.2005.03.011","volume":"20","author":"JLR Martin","year":"2005","unstructured":"Martin JLR, P\u00e9rez V, Sacrist\u00e1n M, \u00c1lvarez E. Is grey literature essential for a better control of publication bias in psychiatry? An example from three meta-analyses of schizophrenia. Eur Psychiatry. 2005;20(8):550\u20133. https:\/\/doi.org\/10.1016\/j.eurpsy.2005.03.011.","journal-title":"Eur Psychiatry"},{"issue":"9","key":"1070_CR18","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","volume":"65","author":"D Hoy","year":"2012","unstructured":"Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65(9):934\u20139. https:\/\/doi.org\/10.1016\/j.jclinepi.2011.11.014.","journal-title":"J Clin Epidemiol"},{"key":"1070_CR19","volume-title":"The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"GA Wells","year":"2014","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Canada: Ottawa Hospital Research Institute; 2014."},{"key":"1070_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2288-8-45","volume":"8","author":"J Thomas","year":"2008","unstructured":"Thomas J, Harden A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol. 2008;8:45. https:\/\/doi.org\/10.1186\/1471-2288-8-45.","journal-title":"BMC Med Res Methodol"},{"key":"1070_CR21","volume-title":"Basics of qualitative research: techniques and procedures for developing grounded theory","author":"J Corbin","year":"2015","unstructured":"Corbin J, Strauss A. Basics of qualitative research: techniques and procedures for developing grounded theory. 4th ed. Los Angeles: SAGE; 2015.","edition":"4"},{"issue":"7121","key":"1070_CR22","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1136\/bmj.315.7121.1533","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Philips AN. Meta-analysis: principles and procedures. BMJ. 1997;315(7121):1533\u20137. https:\/\/doi.org\/10.1136\/bmj.315.7121.1533.","journal-title":"BMJ"},{"key":"1070_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/01621459.2000.10473905","volume":"95","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R. A nonparametric \u201ctrim and fill\u201d method of accounting for publication bias in meta-analysis. J Am Stat Assoc. 2000;95:89\u201398. https:\/\/doi.org\/10.1080\/01621459.2000.10473905.","journal-title":"J Am Stat Assoc"},{"issue":"7","key":"1070_CR24","doi-asserted-by":"publisher","first-page":"e012100","DOI":"10.1136\/bmjopen-2016-012100","volume":"6","author":"AM Tolppanen","year":"2016","unstructured":"Tolppanen AM, Taipale H, Koponen M, Lavikainen P, Tanskanen A, Tiihonen J. Cohort profile: the Finnish Medication and Alzheimer\u2019s disease (MEDALZ) study. BMJ Open. 2016;6(7):e012100. https:\/\/doi.org\/10.1136\/bmjopen-2016-012100.","journal-title":"BMJ Open"},{"issue":"1","key":"1070_CR25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/13607863.2019.1691145","volume":"25","author":"AJA Gerritsen","year":"2021","unstructured":"Gerritsen AJA, Bakker C, Bruls E, Verhey FRJ, Pijnenburg YAL, Millenaar JK, et al. Psychotropic drug use in community-dwelling people with young-onset dementia: two-year course and determinants. Aging Ment Health. 2021;25(1):179\u201386. https:\/\/doi.org\/10.1080\/13607863.2019.1691145.","journal-title":"Aging Ment Health"},{"issue":"1","key":"1070_CR26","first-page":"29","volume":"29","author":"M Sapra","year":"2012","unstructured":"Sapra M, Varma A, Sethi R, Vahia I, Chowdhury M, Kim K, et al. Utilization of antipsychotics in ambulatory elderly with dementia in an outpatient setting. Fed Pract. 2012;29(1):29\u201333.","journal-title":"Fed Pract"},{"issue":"9","key":"1070_CR27","doi-asserted-by":"publisher","first-page":"e0243804","DOI":"10.1371\/journal.pone.0243804","volume":"16","author":"AS Efjestad","year":"2021","unstructured":"Efjestad AS, Ihle-Hansen H, Hjellyik V, Engedal K, Blix HS. Sex differences in psychotropic and analgesic drug use before and after initiating treatment with acetylcholinesterase inhibitors. PLoS ONE. 2021;16(9):e0243804. https:\/\/doi.org\/10.1371\/journal.pone.0243804.","journal-title":"PLoS ONE"},{"issue":"2","key":"1070_CR28","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/gps.5018","volume":"34","author":"N Karttunen","year":"2019","unstructured":"Karttunen N, Taipale H, Hamina A, Taskanen A, Tiihonen J, Tolppanen A-M, et al. Concomitant use of benzodiazepines and opioids in community-dwelling older people with or without Alzheimer\u2019s disease\u2014a nationwide register-based study in Finland. Int J Geriatr Psychiatry. 2019;34(2):280\u20138. https:\/\/doi.org\/10.1002\/gps.5018.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3","key":"1070_CR29","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3233\/jad-150630","volume":"49","author":"L Saarelainen","year":"2016","unstructured":"Saarelainen L, Taipale H, Koponen M, Tanskanen A, Tolppanen A-M, Tiihonen J, et al. The incidence of benzodiazepine and related drug use in persons with and without Alzheimer\u2019s disease. J Alzheimer\u2019s Dis. 2016;49(3):809\u201318. https:\/\/doi.org\/10.3233\/jad-150630.","journal-title":"J Alzheimer\u2019s Dis."},{"issue":"8","key":"1070_CR30","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jalz.2015.02.008","volume":"11","author":"SN Sivananthan","year":"2015","unstructured":"Sivananthan SN, Lavergne MR, McGrail KM. Caring for dementia: a population-based study examining variations in guideline-consistent medical care. Alzheimer\u2019s Dement. 2015;11(8):906\u201316. https:\/\/doi.org\/10.1016\/j.jalz.2015.02.008.","journal-title":"Alzheimer\u2019s Dement."},{"issue":"4","key":"1070_CR31","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/yic.0000000000000080","volume":"30","author":"H Taipale","year":"2015","unstructured":"Taipale H, Koponen M, Tanskanen A, Tolppanen A-M, Tiihonen J, Hartikainen S. Long-term use of benzodiazepines and related drugs among community-dwelling individuals with and without Alzheimer\u2019s disease. Int Clin Psychopharmacol. 2015;30(4):202\u20138. https:\/\/doi.org\/10.1097\/yic.0000000000000080.","journal-title":"Int Clin Psychopharmacol"},{"issue":"2","key":"1070_CR32","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/j.pain.0000000000000752","volume":"158","author":"A Hamina","year":"2017","unstructured":"Hamina A, Taipale H, Tanskanen A, Tolppanen A-M, Karttunen N, Pylkk\u00e4nen L, et al. Long-term use of opioids for nonmalignant pain among community-dwelling persons with and without Alzheimer disease in Finland: a nationwide register-based study. Pain. 2017;158(2):252\u201360. https:\/\/doi.org\/10.1097\/j.pain.0000000000000752.","journal-title":"Pain"},{"issue":"1","key":"1070_CR33","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1017\/s1041610209990780","volume":"22","author":"C Arbus","year":"2010","unstructured":"Arbus C, Gardette V, Bui E, Cantet C, Anrieu S, Nourhash\u00e9mi F, et al. Antidepressant use in Alzheimer\u2019s disease patients: results of the REAL.FR cohort. Int Psychogeriatr. 2010;22(1):120\u20138. https:\/\/doi.org\/10.1017\/s1041610209990780.","journal-title":"Int Psychogeriatr"},{"issue":"7","key":"1070_CR34","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.jagp.2017.03.003","volume":"25","author":"S Bhattacharjee","year":"2017","unstructured":"Bhattacharjee S, Oh YM, Reiman EM, Burke WJ. Prevalence, patterns, and predictors of depression treatment among community-dwelling elderly individuals with dementia in the United States. Am J Geriatr Psychiatry. 2017;25(7):803\u201313. https:\/\/doi.org\/10.1016\/j.jagp.2017.03.003.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"4","key":"1070_CR35","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.3233\/jad-170102","volume":"58","author":"P Cermakova","year":"2017","unstructured":"Cermakova P, Nelson M, Secnik J, Garcia-Ptacek S, Johnell K, Fastbom J, et al. Living alone with Alzheimer\u2019s disease: data from SveDem, the Swedish Dementia Registry. J Alzheimer\u2019s Dis. 2017;58(4):1265\u201372. https:\/\/doi.org\/10.3233\/jad-170102.","journal-title":"J Alzheimer\u2019s Dis."},{"key":"1070_CR36","unstructured":"Drummond N, McCleary L, Freiheit E, Molnar F, Dalziel W, Cohen C, et al. Antidepressant and antipsychotic prescribing in primary care for people with dementia. Can Fam Physician. 2018;64:e488\u201397. https:\/\/www.cfp.ca\/content\/cfp\/64\/11\/e488.full.pdf"},{"issue":"1","key":"1070_CR37","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/gps.4450","volume":"32","author":"A Puranen","year":"2017","unstructured":"Puranen A, Taipale H, Koponen M, Tanskanen A, Tolppanen A-M, Tiihonen J, et al. Incidence of antidepressant use in community-dwelling persons with and without Alzheimer\u2019s disease: 13-year follow-up. Int J Geriatr Psychiatry. 2017;32(1):94\u2013101. https:\/\/doi.org\/10.1002\/gps.4450.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"12","key":"1070_CR38","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1080\/13607863.2015.1075960","volume":"20","author":"EL Grace","year":"2016","unstructured":"Grace EL, Burgio LD, Allen RS, DeCoster J, Aiello AE, Algase DL. Caregiver and care recipient characteristics as predictors of psychotropic medication use in community-dwelling dementia patients. Aging Ment Health. 2016;20(12):1297\u2013304. https:\/\/doi.org\/10.1080\/13607863.2015.1075960.","journal-title":"Aging Ment Health"},{"key":"1070_CR39","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.2147\/cia.s218641","volume":"14","author":"AM Bargagli","year":"2019","unstructured":"Bargagli AM, Cascini S, Agabiti N, Kirchmayer U, Marino C, Davoli M. Determinants of antipsychotic drugs prescription among community-living older adults with dementia: a population-based study using health information systems in the Lazio region, Italy. Clin Interv Aging. 2019;14:2071\u201383. https:\/\/doi.org\/10.2147\/cia.s218641.","journal-title":"Clin Interv Aging"},{"issue":"2","key":"1070_CR40","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/09638237.2016.1244720","volume":"26","author":"R Kester","year":"2017","unstructured":"Kester R, Un\u00fctzer J, Hogan D, Huang H. Antipsychotic prescribing patterns in a Medicare Advantage population of older individuals with dementia. J Ment Health. 2017;26(2):167\u201371. https:\/\/doi.org\/10.1080\/09638237.2016.1244720.","journal-title":"J Ment Health"},{"issue":"3","key":"1070_CR41","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1080\/13607863.2018.1544211","volume":"24","author":"M Nili","year":"2020","unstructured":"Nili M, Shen C, Sambamoorthi U. Low-value care: antipsychotic medication use among community-dwelling Medicare beneficiaries with Alzheimer\u2019s disease and related dementias and without severe mental illness. Aging Ment Health. 2020;24(3):504\u201310. https:\/\/doi.org\/10.1080\/13607863.2018.1544211.","journal-title":"Aging Ment Health"},{"issue":"4","key":"1070_CR42","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1176\/appi.neuropsych.15010020","volume":"27","author":"GL Xiong","year":"2015","unstructured":"Xiong GL, Filshtein T, Beckett LA, Hinton L. Antipsychotic use in a diverse population with dementia: a retrospective review of the National Alzheimer\u2019s Coordinating Center database. J Neuropsychiatry Clinic Neurosci. 2015;27(4):326\u201332. https:\/\/doi.org\/10.1176\/appi.neuropsych.15010020.","journal-title":"J Neuropsychiatry Clinic Neurosci."},{"issue":"10","key":"1070_CR43","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1017\/s1041610211001621","volume":"23","author":"M-L Laitinen","year":"2011","unstructured":"Laitinen M-L, Bell JS, Lavikainen P, L\u00f6nnroos E, Sulkava R, Hartikainen S. Nationwide study of antipsychotic use among community-dwelling persons with Alzheimer\u2019s disease in Finland. Int Psychogeriatr. 2011;23(10):1623\u201331. https:\/\/doi.org\/10.1017\/s1041610211001621.","journal-title":"Int Psychogeriatr"},{"issue":"5","key":"1070_CR44","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1192\/bjp.bp.114.162834","volume":"207","author":"M Koponen","year":"2015","unstructured":"Koponen M, Tolppanen A-M, Taipale H, Tanskanen A, Tiihonen J, Johnell K, et al. Incidence of antipsychotic use in relation to diagnosis of Alzheimer\u2019s disease among community-dwelling persons. Br J Psychiatry. 2015;207(5):444\u20139. https:\/\/doi.org\/10.1192\/bjp.bp.114.162834.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"1070_CR45","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3233\/jad-180594","volume":"66","author":"T Sarycheva","year":"2018","unstructured":"Sarycheva T, Taipale H, Lavikainen P, Tiihonen J, Tanskanen A, Hartikainen S, et al. Incidence and prevalence of antiepileptic medication use in community-dwelling persons with and without Alzheimer\u2019s disease. J Alzheimer\u2019s Dis. 2018;66(1):387\u201395. https:\/\/doi.org\/10.3233\/jad-180594.","journal-title":"J Alzheimer\u2019s Dis."},{"issue":"4","key":"1070_CR46","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1080\/13607863.2017.1286451","volume":"22","author":"EL Grace","year":"2018","unstructured":"Grace EL, Allen RS, Ivey K, Knapp SM, Burgio LD. Racial and ethnic differences in psychotropic medication use among community-dwelling persons with dementia in the United States. Aging Ment Health. 2018;22(4):458\u201367. https:\/\/doi.org\/10.1080\/13607863.2017.1286451.","journal-title":"Aging Ment Health"},{"issue":"6","key":"1070_CR47","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1093\/ageing\/afw141","volume":"45","author":"H Taipale","year":"2016","unstructured":"Taipale H, Koponen M, Tanskanen A, Tolppanen A-M, Tiihonen J, Hartikainen S. Drug use in persons with and without Alzheimer\u2019s disease aged 90 years or more. Age Ageing. 2016;45(6):900\u20134. https:\/\/doi.org\/10.1093\/ageing\/afw141.","journal-title":"Age Ageing"},{"issue":"11","key":"1070_CR48","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1111\/j.1532-5415.2011.03660.x","volume":"59","author":"Y Rhee","year":"2011","unstructured":"Rhee Y, Csernansky JG, Emanuel LL, Chang C-G, Shega JW. Psychotropic medication burden and factors associated with antipsychotic use: an analysis of a population-based sample of community-dwelling older persons with dementia. J Am Geriatr Soc. 2011;59(11):2100\u20137. https:\/\/doi.org\/10.1111\/j.1532-5415.2011.03660.x.","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"1070_CR49","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.euroneuro.2014.10.004","volume":"24","author":"H Taipale","year":"2014","unstructured":"Taipale H, Koponen M, Tanskanen A, Tolppanen A-M, Tiihonen J, Hartikainen S. High prevalence of psychotropic drug use among persons with and without Alzheimer\u2019s disease in Finnish nationwide cohort. Eur Neuropsychopharmacol. 2014;24(11):1729\u201337. https:\/\/doi.org\/10.1016\/j.euroneuro.2014.10.004.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"10","key":"1070_CR50","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1001\/jama.2021.1195","volume":"325","author":"DT Maust","year":"2021","unstructured":"Maust DT, Strominger J, Myra Kim H, Langa KM, Bynum JPW, Chang C-H, et al. Prevalence of central nervous system\u2014active polypharmacy among older adults with dementia in the US. J Am Med Assoc. 2021;325(10):952\u201361. https:\/\/doi.org\/10.1001\/jama.2021.1195.","journal-title":"J Am Med Assoc"},{"issue":"4","key":"1070_CR51","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3233\/jad-140282","volume":"41","author":"H Taipale","year":"2014","unstructured":"Taipale H, Koponen M, Tanskanen A, Tolppanen A-M, Tiihonen J, Hartikainen S. Antipsychotic polypharmacy among a nationwide sample of community-dwelling persons with Alzheimer\u2019s disease. J Alzheimer\u2019s Dis. 2014;41(4):1223\u20138. https:\/\/doi.org\/10.3233\/jad-140282.","journal-title":"J Alzheimer\u2019s Dis."},{"issue":"4","key":"1070_CR52","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3233\/jad-141554","volume":"43","author":"T Eichler","year":"2015","unstructured":"Eichler T, Wucherer D, Thyrian JR, Kilimann I, Hertel J, Nichalowsky B, et al. Antipsychotic drug treatment in ambulatory dementia care: prevalence and correlates. J Alzheimer\u2019s Dis. 2015;43(4):13\u201311. https:\/\/doi.org\/10.3233\/jad-141554.","journal-title":"J Alzheimer\u2019s Dis."},{"issue":"7","key":"1070_CR53","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.jamda.2020.12.021","volume":"22","author":"A Hakala","year":"2021","unstructured":"Hakala A, Tolppanen A-M, Koponen M, Taipale H, Tanskanen A, Hartikainen S, et al. Does recent hospitalization increase antipsychotic initiation among community dwellers with Alzheimer\u2019s disease? J Am Med Dir Assoc. 2021;22(7):1543\u20137. https:\/\/doi.org\/10.1016\/j.jamda.2020.12.021.","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"1070_CR54","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12877-017-0636-8","volume":"17","author":"S Rios","year":"2017","unstructured":"Rios S, Perlman CM, Costa A, Heckman G, Hirdes JP, Mitchell L. Antipsychotics and dementia in Canada: a retrospective cross-sectional study of four health sectors. BMC Geriatr. 2017;17(1):244. https:\/\/doi.org\/10.1186\/s12877-017-0636-8.","journal-title":"BMC Geriatr"},{"issue":"4","key":"1070_CR55","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/jcp.0000000000000133","volume":"34","author":"H Taipale","year":"2014","unstructured":"Taipale H, Koponen M, Tanskanen A, Tolppanen A-M, Tiihonen J, Hartikainen S. Antipsychotic doses among community-dwelling persons with Alzheimer disease in Finland. J Clin Psychopharmacol. 2014;34(4):435\u201340. https:\/\/doi.org\/10.1097\/jcp.0000000000000133.","journal-title":"J Clin Psychopharmacol"},{"issue":"7","key":"1070_CR56","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1017\/s1041610217002897","volume":"30","author":"A Hamina","year":"2018","unstructured":"Hamina A, Lavikainen P, Tanskanen A, Tolppanen A-M, Tiihonen J, Hartikainen S, et al. Impact of opioid initiation on antipsychotic and benzodiazepine and related drug use among persons with Alzheimer\u2019s disease. Int Psychogeriatr. 2018;30(7):947\u201356. https:\/\/doi.org\/10.1017\/s1041610217002897.","journal-title":"Int Psychogeriatr"},{"issue":"3","key":"1070_CR57","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3233\/jad-200127","volume":"77","author":"MS Aigbogun","year":"2020","unstructured":"Aigbogun MS, Cloutier M, Gauthier-Loiselle M, Guerin A, Ladouceur M, Baker RA, et al. Real-world treatment patterns and characteristics among patients with agitation and dementia in the United States: findings from a large, observational, retrospective chart review. J Alzheimer\u2019s Dis. 2020;77(3):1181\u201394. https:\/\/doi.org\/10.3233\/jad-200127.","journal-title":"J Alzheimer\u2019s Dis."},{"issue":"10","key":"1070_CR58","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1017\/s1041610217001090","volume":"29","author":"S T\u00f6rm\u00e4lehto","year":"2017","unstructured":"T\u00f6rm\u00e4lehto S, Martikainen J, Bell JS, Hallikainen I, Koivisto AM. Use of psychotropic medications in relation to neuropsychiatric symptoms, cognition and functional performance in Alzheimer\u2019s disease over a three-year period: Kuopio ALSOVA study. Int Psychogeriatr. 2017;29(10):1723\u201333. https:\/\/doi.org\/10.1017\/s1041610217001090.","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"1070_CR59","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1017\/s1041610214001987","volume":"27","author":"SJ Teipel","year":"2015","unstructured":"Teipel SJ, Thyrian JR, Hertel J, Eichler T, Wucherer D, Michalowsky B, et al. Neuropsychiatric symptoms in people screened positive for dementia in primary care. Int Psychogeriatr. 2015;27(1):39\u201348. https:\/\/doi.org\/10.1017\/s1041610214001987.","journal-title":"Int Psychogeriatr"},{"issue":"7","key":"1070_CR60","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/gps.5505","volume":"36","author":"A Tarvainen","year":"2021","unstructured":"Tarvainen A, Hartikainen S, Taipale H, Tanskanen A, Koponen M, Tolppanen A-M. Association of recent hospitalisation with antidepressant initiation among community dwellers with Alzheimer\u2019s disease. Int J Geriatr Psychiatry. 2021;36(7):1075\u201384. https:\/\/doi.org\/10.1002\/gps.5505.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"10","key":"1070_CR61","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.euroneuro.2015.07.008","volume":"25","author":"M Koponen","year":"2015","unstructured":"Koponen M, Taipale H, Tanskanen A, Tolppanen A-M, Tiihonen J, Ahonen R, et al. Long-term use of antipsychotics among community-dwelling persons with Alzheimer\u2019s disease: a nationwide register-based study. Eur Neuropsychopharmacol. 2015;25(10):1706\u201313. https:\/\/doi.org\/10.1016\/j.euroneuro.2015.07.008.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"11","key":"1070_CR62","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1080\/13607863.2017.1364347","volume":"22","author":"A Lyons","year":"2018","unstructured":"Lyons A, Alba B, Heywood W, Fileborn B, Minichiello V, Barrett C, et al. Experiences of ageism and the mental health of older adults. Aging Ment Health. 2018;22(11):1456\u201364. https:\/\/doi.org\/10.1080\/13607863.2017.1364347.","journal-title":"Aging Ment Health"},{"issue":"1","key":"1070_CR63","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1054773819838678","volume":"30","author":"B Resnick","year":"2021","unstructured":"Resnick B, Kolanowski A, Van Haitsma K, Galik E, Boltz M, Ellis J, et al. Current psychotropic medication use and contributing factors among nursing home residents with cognitive impairment. Clinic Nurs Res. 2021;30(1):59\u201369. https:\/\/doi.org\/10.1177\/1054773819838678.","journal-title":"Clinic Nurs Res."},{"key":"1070_CR64","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00228-020-02995-w","volume":"77","author":"D Scuteri","year":"2021","unstructured":"Scuteri D, Vulnera M, Piro B, Bossio RB, Morrone LA, Sandrini G, et al. Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dementia. Eur J Clin Pharmacol. 2021;77:241\u20139. https:\/\/doi.org\/10.1007\/s00228-020-02995-w.","journal-title":"Eur J Clin Pharmacol"},{"key":"1070_CR65","doi-asserted-by":"publisher","unstructured":"Braun A, Trivedi DP, Dickenson A, Hamilton L, Goodman C, Gage H, et al. Managing behavioural and psychological symptoms in community dwelling older people with dementia: 2. a systematic review of qualitative studies. Dementia 2019;18(7-8);2950\u201370. https:\/\/doi.org\/10.1177\/1471301218762856","DOI":"10.1177\/1471301218762856"},{"issue":"9","key":"1070_CR66","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1111\/j.1532-5415.2007.01307.x","volume":"55","author":"J Razani","year":"2007","unstructured":"Razani J, Kakos B, Orieta-Barbalace C, Wong JT, Casas R, Lu P, et al. Predicting caregiver burden from daily functional abilities of patients with mild dementia. J Am Geriatr Soc. 2007;55(9):1415\u201320. https:\/\/doi.org\/10.1111\/j.1532-5415.2007.01307.x.","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"1070_CR67","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1093\/gerona\/gly078","volume":"73","author":"D Gnjidic","year":"2018","unstructured":"Gnjidic D, Agogo GO, Ramsey CM, Moga DC, Allore H. The impact of dementia diagnosis on patterns of potentially inappropriate medication use among older adults. J Gerontol Ser A Biol Sci Med Sci. 2018;73(10):1410\u20137. https:\/\/doi.org\/10.1093\/gerona\/gly078.","journal-title":"J Gerontol Ser A Biol Sci Med Sci."},{"issue":"8","key":"1070_CR68","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/s1474-4422(15)00101-5","volume":"14","author":"TG Fong","year":"2015","unstructured":"Fong TG, Davis D, Growdon ME, Albuquerque A, Inouye SK. The interface between delirium and dementia in elderly adults. Lancet Neurol. 2015;14(8):823\u201332. https:\/\/doi.org\/10.1016\/s1474-4422(15)00101-5.","journal-title":"Lancet Neurol"},{"issue":"2","key":"1070_CR69","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1017\/s1041610216001654","volume":"29","author":"S Toot","year":"2017","unstructured":"Toot S, Swinson T, Devine M, Challis D, Orrell M. Causes of nursing home placement for older people with dementia: a systematic review and meta-analysis. Int Psychogeriatr. 2017;29(2):195\u2013208. https:\/\/doi.org\/10.1017\/s1041610216001654.","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"1070_CR70","doi-asserted-by":"publisher","first-page":"CD004396","DOI":"10.1002\/14651858.cd004396.pub3","volume":"16","author":"N Maayan","year":"2014","unstructured":"Maayan N, Soares-Weiser K, Lee H. Respite care for people with dementia and their carers. Cochrane Database Syst Rev. 2014;16(1):CD004396. https:\/\/doi.org\/10.1002\/14651858.cd004396.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"1070_CR71","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1017\/s104161021500232x","volume":"28","author":"S Brunero","year":"2016","unstructured":"Brunero S, Wand APF, Lamont S, John L. A point prevalence study of the use of psychotropic medication in an acute general hospital. Int Psychogeriatr. 2016;28(6):967\u201375. https:\/\/doi.org\/10.1017\/s104161021500232x.","journal-title":"Int Psychogeriatr"},{"issue":"2","key":"1070_CR72","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/ajag.13017","volume":"41","author":"WA Tumusiime","year":"2022","unstructured":"Tumusiime WA, Hardman CJ, Breen JL. Antipsychotic prescribing in people admitted to hospital with dementia or delirium. Australas J Ageing. 2022;41(2):258\u201364. https:\/\/doi.org\/10.1111\/ajag.13017.","journal-title":"Australas J Ageing"},{"issue":"2","key":"1070_CR73","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3233\/jad-210724","volume":"84","author":"S Read","year":"2021","unstructured":"Read S, Hu B, Wittenberg R, Brimblecombe N, Robinson L, Banerjee S. A longitudinal study of functional unmet need among people with dementia. J Alzheimer\u2019s Dis. 2021;84(2):705\u201316. https:\/\/doi.org\/10.3233\/jad-210724.","journal-title":"J Alzheimer\u2019s Dis."},{"issue":"8","key":"1070_CR74","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3109\/09638288.2016.1161848","volume":"39","author":"D Connolly","year":"2017","unstructured":"Connolly D, Garvey J, McKee G. Factors associated with ADL\/IADL disability in community dwelling older adults in the Irish longitudinal study on ageing (TILDA). Disabil Rehabil. 2017;39(8):809\u201316. https:\/\/doi.org\/10.3109\/09638288.2016.1161848.","journal-title":"Disabil Rehabil"},{"issue":"4","key":"1070_CR75","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.amjopharm.2012.05.001","volume":"10","author":"JM Thorpe","year":"2012","unstructured":"Thorpe JM, Thorpe CT, Kennelty KA, Gellad WF, Schulz R. The impact of family caregivers on potentially inappropriate medication use in noninstitutionalized older adults with dementia. Am J Geriatr Pharmacother. 2012;10(4):230\u201341. https:\/\/doi.org\/10.1016\/j.amjopharm.2012.05.001.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"13","key":"1070_CR76","doi-asserted-by":"publisher","first-page":"799723","DOI":"10.3389\/fneur.2022.799723","volume":"25","author":"H Ma","year":"2022","unstructured":"Ma H, Lu X, Zhou A, Wang F, Zuo X, Zhan M, et al. Clinical practice guidelines for the management of behavioral and psychological symptoms of dementia: a systematic review with AGREE II. Front Neurol. 2022;25(13):799723. https:\/\/doi.org\/10.3389\/fneur.2022.799723.","journal-title":"Front Neurol"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01070-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-023-01070-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01070-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T07:06:03Z","timestamp":1701068763000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-023-01070-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,9]]},"references-count":76,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1070"],"URL":"https:\/\/doi.org\/10.1007\/s40266-023-01070-0","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"type":"print","value":"1170-229X"},{"type":"electronic","value":"1179-1969"}],"subject":[],"published":{"date-parts":[[2023,11,9]]},"assertion":[{"value":"6 September 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open Access funding enabled and organized by CAUL and its Member Institutions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Raw data is available on request from the corresponding author.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"KL designed the study, conducted the research, wrote the manuscript, and revised the manuscript following editorial and peer review following discussion and agreement with the authorship group. CP designed the study, conducted the research, and assisted in writing of the manuscript. AW and JB were involved in design of the study, review of the data, and writing and review of the manuscript. GH was involved in statistical planning and conduct of the meta-analysis, and writing and review of the manuscript. All authors have read the revised version of the manuscript and are accountable for the final contents.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}